
WB analysis of whole cell extracts (30 microg lysate) of COS-7 (Lane 1) treated with 100 uM Pervanadate for 1 hour (Lane 2), A431 (Lane 3) treated with 100 uM Pervanadate for 1 hour (Lane 4), HeLa (Lane 5) treated with 100 uM Pervanadate for 1 hour (Lane 6) using GTX24833 Paxillin (phospho Tyr118) antibody. Dilution : 1:500
Paxillin (phospho Tyr118) antibody
GTX24833
ApplicationsImmunoFluorescence, ImmunoPrecipitation, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
TargetPXN
Overview
- SupplierGeneTex
- Product NamePaxillin (phospho Tyr118) antibody - Orthogonal Validated
- Delivery Days Customer9
- Application Supplier NoteWB: 1:500. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsImmunoFluorescence, ImmunoPrecipitation, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityPolyclonal
- ConjugateUnconjugated
- Gene ID5829
- Target namePXN
- Target descriptionpaxillin
- Target synonymspaxillin, testicular tissue protein Li 134
- HostRabbit
- IsotypeIgG
- Protein IDP49023
- Protein NamePaxillin
- Scientific DescriptionThis gene encodes a cytoskeletal protein involved in actin-membrane attachment at sites of cell adhesion to the extracellular matrix (focal adhesion). Alternatively spliced transcript variants encoding different isoforms have been described for this gene. These isoforms exhibit different expression pattern, and have different biochemical, as well as physiological properties (PMID:9054445). [provided by RefSeq, Aug 2011]
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Tenascin-C enhances pancreatic cancer cell growth and motility and affects cell adhesion through activation of the integrin pathway. Paron I et al., 2011, PLoS OneRead more
- Type I collagen promotes the malignant phenotype of pancreatic ductal adenocarcinoma. Armstrong T et al., 2004 Nov 1, Clin Cancer ResRead more





